KatarinaLuptakovaMD
Hematology • Boston, MAHematologic Oncology
Instructor in Medicine, Beth Israel Deaconess Medical Center
Dr. Luptakova is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Caritas St Elizabeths Medical Center
736 Cambridge Street
Boston, MA 02135Phone+1 617-789-3000
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
St Elizabeth's Medical CenterResidency, Internal Medicine, 2003 - 2006
Comenius UniversityClass of 2000
Certifications & Licensure
MA State Medical License 2006 - 2023
Clinical Trials
- Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML) Start of enrollment: 2011 Sep 01
- Lenalidomide After Allo Transplant Start of enrollment: 2012 Dec 01
- Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma Start of enrollment: 2015 Dec 01
Publications & Presentations
PubMed
- 320 citationsNiraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trialKathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller, David Miller, N.G. Cloven
The Lancet. Oncology. 2019-05-01 - 29 citationsProlonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United ...Parameswaran Hari, Dorothy Romanus, Antonio Palumbo, Katarina Luptakova, Robert M. Rifkin
Clinical Lymphoma, Myeloma & Leukemia. 2018-02-01 - 185 citationsInterpreting clinical trial data in multiple myeloma: translating findings to the real-world settingPaul G. Richardson, Jesús F. San Miguel, Philippe Moreau, Roman Hájek, Meletios A. Dimopoulos
Blood Cancer Journal. 2018-11-09
Press Mentions
The Courage of Patients in Phase 1 Cancer TrialsMay 31st, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
